Results 361 to 370 of about 370,815 (388)
Some of the next articles are maybe not open access.

Precipitation of fibrin monomers and fibrin degradation products by ristocetin

The American Journal of the Medical Sciences, 1978
Ristocetin, at relatively low concentrations (1.0 mg/ml-1.5 mg/ml), can selectively precipitate fibrin monomers and fibrin degradation products (fdp) from plasma without effect on fibrinogen or fibrinogen degradation products (FDP). 125I-labeled fibrin monomers and fibrin degradation products were precipitated by ristocetin when their plasma ...
Kiyoaki Watanabe, James L. Tullis
openaire   +3 more sources

THE STRUCTURE OF FIBRINOGEN AND FIBRIN: II. ARCHITECTURE OF THE FIBRIN CLOT*

Annals of the New York Academy of Sciences, 1983
Our present low resolution model for fibrinogen based on electron microscopy and x-ray diffraction data has been described by Cohen et al. A unique aspect of the structural analysis of fibrous proteins is that the molecular packing in ordered arrays reflects biologically significant intermolecular interactions.
Carolyn Cohen   +2 more
openaire   +3 more sources

Insertion of fibrin peptides into urokinase enhances fibrin affinity

Thrombosis Research, 1990
Low molecular weight two-chain urokinase is a 33-kD plasminogen activator, which has no innate affinity for fibrin and consequently, its use to facilitate lysis of blood clots may lead to systemic activation of plasminogen. In order to impart clot affinities to this urokinase form (UK) we have generated two novel fibrin-binding derivatives by partially
T. Wai, G.A. Homandberg
openaire   +3 more sources

Fibrin Formation: The Role of the Fibrinogen-Fibrin Monomer Complex

Thrombosis and Haemostasis, 1976
SummaryThe process of fibrin formation using highly purified fibrinogen and thrombin was studied using laser fluctuation spectroscopy, a method that rapidly determines particle size in a solution. Two periods in fibrin clot formation were noted: an induction period during which no fibrin polymerization occurred and a period of rapid increase in ...
Robert V. Edwards   +3 more
openaire   +3 more sources

Fibrin deposition and fibrin degradation products in atherosclerotic plaques

Thrombosis Research, 1994
Soluble fibrin/fibrinogen-related antigens and insoluble fibrin are present in virtually all samples of human aortic intima. Components of the soluble fraction were identified by SDS-PAGE and immunoblotting with specific antisera. The fibrinogen was characterized by increased proportions of low molecular mass (Mr) species (300 and 280 kD), the FDP by ...
openaire   +3 more sources

Fibrin in hepatocytes

Die Naturwissenschaften, 1967
E. W. Parry, F. N. Ghadially
openaire   +3 more sources

Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?

Clinical Oral Investigations, 2017
R. Miron   +6 more
semanticscholar   +1 more source

Fibrin and Cancer

Thrombosis and Haemostasis, 1993
Vincenzo Costantini, Leo R. Zacharski
openaire   +2 more sources

Fibrin

2011
Fibrin, derived from key proteins involved in blood clotting (fibrinogen and thrombin), is a self-assembling biopolymer. The range of clinical applications and types of procedure that incorporate fibrin sealants is expanding. While fibrin sealants have been initially used for their hemostasis and tissue sealing properties, they have also been recently ...
openaire   +2 more sources

Optimized Platelet‐Rich Fibrin With the Low‐Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response

The Journal of Periodontology, 2017
M. Fujioka-Kobayashi   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy